Technical Analysis for HUGE - FSD Pharma Inc. - Class B Subordinate Voting Shares
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
3.8 | 0.26% | 0.01 |
HUGE closed up 0.26 percent on Friday, July 10, 2020, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Historical HUGE trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 0.26% | |
| Narrow Range Bar | Range Contraction | 0.26% | |
| NR7 | Range Contraction | 0.26% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Drug Manufacturers—Specialty & Generic
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Cobourg, Canada.
Medicine Health Autoimmune Diseases Health Sciences Central Nervous System Disorders Chronic Pain Medical Cannabis Antiemetics Antioxidants
Medicine Health Autoimmune Diseases Health Sciences Central Nervous System Disorders Chronic Pain Medical Cannabis Antiemetics Antioxidants
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 32.06 |
| 52 Week Low | 0.0 |
| Average Volume | 438,356 |
| 200-Day Moving Average | 5.23 |
| 50-Day Moving Average | 3.75 |
| 20-Day Moving Average | 4.01 |
| 10-Day Moving Average | 3.83 |
| Average True Range | 0.43 |
| ADX | 36.75 |
| +DI | 34.99 |
| -DI | 17.22 |
| Chandelier Exit (Long, 3 ATRs ) | 3.80 |
| Chandelier Exit (Short, 3 ATRs ) | 4.93 |
| Upper Bollinger Band | 4.45 |
| Lower Bollinger Band | 3.58 |
| Percent B (%b) | 0.26 |
| BandWidth | 21.73 |
| MACD Line | -0.05 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0532 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.06 | ||||
| Resistance 3 (R3) | 4.06 | 3.98 | 4.01 | ||
| Resistance 2 (R2) | 3.98 | 3.92 | 3.98 | 4.00 | |
| Resistance 1 (R1) | 3.89 | 3.87 | 3.85 | 3.89 | 3.98 |
| Pivot Point | 3.81 | 3.81 | 3.79 | 3.81 | 3.81 |
| Support 1 (S1) | 3.72 | 3.75 | 3.68 | 3.72 | 3.62 |
| Support 2 (S2) | 3.64 | 3.70 | 3.64 | 3.60 | |
| Support 3 (S3) | 3.55 | 3.64 | 3.59 | ||
| Support 4 (S4) | 3.55 |
